Sinopharm vaccine

Sinopharm vaccine

FILE PHOTO: A vial labelled "Sinopharm COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration

Some Omicron sub-variants escaping antibodies from Sinopharm shot

A nurse holds a vial of China's Sinopharm coronavirus disease (COVID-19) vaccine at a health center in Caracas, Venezuela March 7, 2021. REUTERS/Leonardo Fernandez Viloria

Local production of Sinopharm vaccine uncertain

File photo

55 lakh more doses of Sinopharm vaccine arrive from China

Sinopharm has become the first non-Western vaccine that is approved by WHO. Photo: Reuters.

Govt to buy 7.5 crore doses of Sinopharm vaccine: Minister

Sinopharm has become the first non-Western vaccine that is approved by WHO. Photo: Reuters.

30 lakh more doses of Sinopharm vaccine to arrive tonight

Govt to buy 1.5cr Sinopharm shots at lower price

Govt to buy 1.5cr Sinopharm shots at lower price

Photo: Courtesy

Additional Secretary made OSD soon after disclosing price of Chinese vaccine

A nurse holds a vial of China's Sinopharm coronavirus disease (COVID-19) vaccine at a health center in Caracas, Venezuela March 7, 2021. REUTERS/Leonardo Fernandez Viloria

Sinopharm vaccine: Efforts underway to normalise things after price disclosure

Sinopharm has become the first non-Western vaccine that is approved by WHO. Photo: Reuters.

Chinese citizens get Sinopharm vaccine at DMCH

Sinopharm has become the first non-Western vaccine that is approved by WHO. Photo: Reuters.

Bangladesh approves proposal to buy Chinese Covid-19 vaccine at $10 per dose

Photo: Collected

5 lakh doses of Chinese vaccine reach Dhaka

China's State Councilor and Foreign Minister Wang Yi and UAE's Foreign Minister Abdullah Bin Zayed Al Nahyan show the Chines made Coronavirus (COVID-19) vaccine Sinopharm during their meeting in Abu Dhabi, United Arab Emirates, March 28, 2021. WAM/Handout via REUTERS

New UAE plant to make Covid-19 vaccine from China's Sinopharm

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang

Sinopharm needs trial results to decide if Covid-19 shot needs booster: Executive